Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!
All content for On The Pen With Dave Knapp is the property of Bleav, Dave Knapp Founder of On The Pen and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!
GLP-1 Compound Legislation: States are the Next Battlefield w/ Sabina Hemme
On The Pen With Dave Knapp
59 minutes 5 seconds
1 day ago
GLP-1 Compound Legislation: States are the Next Battlefield w/ Sabina Hemme
Don’t miss this live conversation with Sabina from GLPwinner.com as she joins us to discuss the next legal battlefield for compounds: states. We also discuss how the federal legislation is likely a messaging bill to help advance state agendas.
On The Pen With Dave Knapp
Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!
